Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Morgan Stanley & Co. Incorporated, Medical Equipment Deals Advised By Year, 2004 to YTD 2009 8
Morgan Stanley & Co. Incorporated, Medical Equipment Deals Advised By Type, 2004 to YTD 2009 9
Morgan Stanley & Co. Incorporated, Medical Equipment Deals Advised By Region, 2004 to YTD 2009 10
Morgan Stanley & Co. Incorporated, Medical Equipment Deals Advised By Market, 2004 to YTD 2009 11
Morgan Stanley & Co. Incorporated, Medical Equipment Deals Advised Summary, 2004 to YTD 2009 12
Morgan Stanley & Co. Incorporated, Medical Equipment, Deal Details 18
Merger Deals 18
Invitrogen Merges With Applied Biosystems To Form Life Technologies 18
Acquisition 19
Olympus Acquires Gyrus Group 19
The Dow Chemical Company Acquires Rohm and Haas 21
Endo Pharmaceuticals Acquires Indevus Pharmaceuticals 23
Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 25
Abbott Laboratories Acquires Advanced Medical Optics 26
Cardiovascular Systems Acquires Replidyne 28
Hologic Acquires Cytyc For $6,200 Million 30
Technitrol Acquires Sonion 32
Fresenius Medical Acquires Renal Solutions 33
IBA Health Acquires iSoft Group 34
Boston Scientific Acquires Guidant 35
Allergan Acquires Inamed 37
Advanced Medical Optics Acquires VISX 38
Smiths Group Acquires Medex 39
The Cooper Companies Acquires Ocular Sciences 40
Cytyc Acquires Novacept 42
Private Equity 43
Blackstone, DLJ Merchant, Goldman Sachs to acquire UICI 43
Warburg Pincus Acquires Bausch & Lomb 44
Nordic Capital Fund And Avista Capital Partners Acquire ConvaTec From Bristol-Myers Squibb 46
Equity Offerings 47
MedAssets Completes Initial Public Offering Of $244.72 Million 47
EnteroMedics Completes Initial Public Offering Of $43.92 Million 48
Hansen Medical Completes Public Offering Of $40.02 Million 49
Emdeon Completes Initial Public Offering Of $166.24 Million 51
Beckman Coulter Completes Public Offering Of Common Stock For $250 Million 53
Hansen Medical Completes Initial Public Offering Of $86.25 Million 55
Conor Medsystems Completes $96.25 Million Public Offering 56
Danaher Completes Public Offering Of $567.53 Million 57
MAKO Surgical Completes Initial Public Offering Of $51 Million 59
Biodel Completes Public Offering of $50.5 Million 60
Advanced Magnetics Completes Public Offering Of $130 Million 62
AMAG Pharmaceuticals Completes Public Offering Of $130 Million 64
MAP Pharmaceuticals Completes Initial Public Offering Of $69 Million 66
AMAG Pharmaceuticals Completes Public Offering Of $162.85 Million 67
Biodel Completes Initial Public Offering Of $86.3 Million 69
Alexza Pharmaceuticals Completes Public Offering Of $70.73 Million 70
ABIOMED Completes Public Offering Of $69.85 Million 72
Epigenomics Completes Initial Public Offering Of $64.68 Million 74
ABIOMED Completes Public Offering Of $42.06 Million 75
Grifols Completes Initial Public Offering Of $415.49 Million 76
Myriad Genetics Completes Public Offering Of $50.2 Million 77
Debt Offerings 79
Cardinal Health Completes Public Offering Of 5.85% Senior Notes For $500 Million 79
Quest Diagnostics Completes Private Placement Of 5.125% Senior Notes For $400 Million 80
Medtronic Completes Private Placement Of 1.5% Convertible Senior Notes For $2,200 Million 81
Medtronic Completes Private Placement Of 1.625% Convertible Senior Notes For $2,200 Million 82
Allergan Completes Private Placement Of $750 Million 83
Allergan Completes Private Placement Of $800 Million 84
Advanced Medical Optics Completes Private Placement Of $350 Million 85
Abbott Laboratories Completes Public Offering Of Notes Due 2014 For $500 Million 86
Abbott Laboratories Completes Public Offering Of Notes Due 2011 For $500 Million 87
Wyeth Completes Public Offering Of $2,000 Million Senior Notes 88
Wyeth Completes Public Offering Of $500 Million Senior Notes 89
Hospira Completes Public Offering Of Floating Rate Notes For $375 Million 90
Hospira Completes Public Offering Of 5.55% Notes For $500 Million 91
Hospira Completes Public Offering Of 6.05% Notes For $550 Million 92
Eli Lilly Completes Public Offering Of 5.2% Notes For $1,000 Million 93
Eli Lilly Completes Public Offering Of 5.5% Notes For $696 Million 94
Eli Lilly Completes Public Offering Of 5.55% Notes For $795 Million 95
Beckman Coulter Completes Private Placement Of $600 Million 96
Johnson & Johnson Completes Public Offering Of 5.15% Notes Due 2012 For $600 Million 97
Johnson & Johnson Completes Public Offering Of 5.55% Notes Due 2017 For $1,000 Million 98
Johnson & Johnson Completes Public Offering Of 5.95% Notes Due 2037 For $1,000 Million 100
Kimberly-Clark Completes Public Offering Of Floating Rate Notes For $450 Million 101
Kimberly-Clark Completes Public Offering Of Floating Rate Notes For $700 Million 102
Kimberly-Clark Completes Public Offering Of Floating Rate Notes For $950 Million 103
Quest Diagnostics Completes Public Offering Of 6.4% Senior Notes For $375 Million 104
Quest Diagnostics Completes Public Offering Of 6.95% Senior Notes For $425 Million 105
Dupont Completes 5.25% Notes Offering For $600 Million 106
DuPont Completes 5.6% Notes Offering For $400 Million 107
Abbott Laboratories Completes Public Offering Of 5.375% Notes For $500 Million 108
Abbott Laboratories Completes Public Offering Of Notes Due 2011 For $1,500 Million 110
Abbott Laboratories Completes Public Offering Of Notes Due 2016 For $2,000 Million 112
Cardinal Health Completes Private Placement Of 5.8% Senior Notes For $500 Million 114
Cardinal Health Completes Private Placement Of Floating Rate Senior Notes For $350 Million 115
Beckman Coulter Completes Public Offering Of 6% Senior Notes For $250 Million 116
Beckman Coulter Completes Public Offering Of 7% Senior Notes For $250 Million 117
Becton, Dickinson and Company Completes Public Offering Of 6% Notes For $250 Million 118
Becton, Dickinson and Company Completes Public Offering Of 5% Notes For $500 Million 119
Smiths Group Completes 6.05% Senior Notes Offering For $250 Million 120
Smiths Group Completes 7.2% Senior Notes Offering For $250 Million 121
Jabil Circuit Completes Public Offering Of 7.75% Senior Notes For $312 Million 122
Hospira Completes Public Offering Of 6.4% Notes For $250 Million 124
DuPont Issues $398.86 Million 4.75% Notes Due 2015 125
DuPont Issues $498.23 Million 5.75% Notes Due 2019 126
Novartis Completes Public Offering Of 4.125% Bonds For $2,000 Million 127
Novartis Completes Public Offering Of 5.125% Bonds For $3,000 Million 128
DuPont Completes Senior Notes Offering Of $1,000 Million 129
Kimberly-Clark Completes Public Offering Of 7.5% Notes For $500 Million 130
Biogen Idec Completes Public Offering Of 6.875% Senior Unsecured Notes For $550 Million 131
Biogen Idec Completes Public Offering Of 6% Senior Unsecured Notes For $450 Million 132
China Medical Technologies Completes Public Offering Of Convertible Senior Notes For $276 Million 133
Indevus Pharmaceutical Completes Private Placement Of $105 Million 134
Dupont Completes 5% Notes Offering For $750 Million 135
Abbott Laboratories Completes Public Offering Of Notes Due 2012 For $1,000 Million 136
Abbott Laboratories Completes Public Offering Of Notes Due 2017 For $1,500 Million 138
Abbott Laboratories Completes Public Offering Of Notes Due 2037 For $1,000 Million 140
Dupont Completes 5% Notes Offering For $750 Million 142
Dupont Completes 6% Notes Offering For $1.25 Billion 144
Cardinal Health Completes Public Offering Of 5.5% Notes For $300 Million 146
Bristol-Myers Completes Public Offering Of 5.45% Senior Notes For $600 Million 147
Bristol-Myers Completes Public Offering Of 6.125% Senior Notes For $1,000 Million 148
Abbott Laboratories Completes Public Offering Of 5.125% Notes For $2,000 Million 149
Abbott Laboratories Completes Public Offering Of 6% Notes For $1,000 Million 151
Asset Transactions 153
Advanced Medical Optics Acquires Surgical Ophthalmology Business From Pfizer 153
Appendix 155
Methodology 155
About Global Markets Direct 155
Contact Us 155
Disclaimer 155
